查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1347565

神經調節市場：2023-2028 年全球行業趨勢、佔有率、規模、成長、機遇和預測

Neuromodulation Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日期: | 出版商: IMARC | 英文 141 Pages | 商品交期: 2-3個工作天內

價格

市場概況：

2022年全球神經調節市場規模達到67億美元。展望未來，IMARC Group預計到2028年市場規模將達到125億美元，2023-2028年年複合成長率（CAGR）為10.4%。

神經調節是一種通過將電劑或藥劑直接輸送到目標區域來調節和改變神經活動的醫療技術。它由微小電極組成，在脈衝發生器的幫助下產生電刺激，以補充患者的神經活動。電極通常放置在神經、大腦或脊髓中，而脈衝發生器則植入皮膚內。神經調節廣泛用於治療抑鬱症、慢性疼痛、癲癇、震顫、偏頭痛、背部衰竭症候群、帕金森氏症和胃輕癱。它包括迷走神經、深部大腦、經顱磁和電刺激。它有助於監測神經活動、緩解症狀並使大腦活動水平正常化。

神經調節市場趨勢：

全球老年人口的增加以及阿滋海默症和帕金森氏症的患病率不斷上升是推動市場成長的關鍵因素。神經調節廣泛用於治療膀胱過度活動症、運動能力低下、強直、震顫、行走問題、神經退行性疾病和神經系統疾病。此外，技術創新，例如提供高能量密度、可充電性和更高循環溫度的鋰離子電池的推出，為市場成長提供了相當大的推動力。此外，脊髓刺激（SCS）在複雜區域疼痛症候群、神經病變、神經損傷、背部手術失敗症候群和蛛網膜炎等各種醫療問題中的廣泛應用，對市場成長產生了積極影響。除此之外，提供低雙極或單極電脈衝並用於治療抑鬱症和強迫症（OCD）的深部腦刺激（DBS）的使用越來越多，正在為市場創造積極的前景。其他因素，例如廣泛的研發 (R&D) 活動和醫療保健行業的顯著成長，預計將推動市場成長。

本報告回答的關鍵問題：

  • 迄今為止，全球神經調節市場的表現如何，未來幾年將如何表現？
  • COVID-19 對全球神經調節市場有何影響？
  • 主要區域市場有哪些？
  • 基於技術的市場細分是什麼？
  • 基於生物材料的市場細分是什麼？
  • 基於應用程式的市場細分是什麼？
  • 行業價值鏈的各個階段是什麼？
  • 該行業的關鍵促進因素和挑戰是什麼？
  • 全球神經調節市場的結構如何？誰是主要參與者？
  • 行業競爭程度如何？

目錄

第一章：前言

第 2 章：範圍和方法

  • 研究目的
  • 利益相關者
  • 數據源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球神經調節市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章：按技術分類的市場

  • 內部神經調節
    • 市場走向
    • 關鍵環節
      • 脊髓刺激 (SCS)
      • 深部腦刺激 (DBS)
      • 迷走神經刺激 (VNS)
      • 骶神經刺激 (SNS)
      • 胃電刺激 (GES)
    • 市場預測
  • 外部神經調節
    • 市場走向
    • 關鍵環節
      • 經皮電神經刺激 (TENS)
      • 經顱磁刺激 (TMS)
      • 其他
    • 市場預測

第 7 章：生物材料市場細分

  • 金屬生物材料
    • 市場走向
    • 市場預測
  • 高分子生物材料
    • 市場走向
    • 市場預測
  • 陶瓷生物材料
    • 市場走向
    • 市場預測

第 8 章：按應用分類的市場細分

  • 帕金森氏症
    • 市場走向
    • 市場預測
  • 癲癇
    • 市場走向
    • 市場預測
  • 沮喪
    • 市場走向
    • 市場預測
  • 肌張力障礙
    • 市場走向
    • 市場預測
  • 疼痛管理
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 9 章：按地區分類的市場細分

  • 北美
    • 美國
      • 市場走向
      • 市場預測
    • 加拿大
      • 市場走向
      • 市場預測
  • 亞太
    • 中國
      • 市場走向
      • 市場預測
    • 日本
      • 市場走向
      • 市場預測
    • 印度
      • 市場走向
      • 市場預測
    • 韓國
      • 市場走向
      • 市場預測
    • 澳大利亞
      • 市場走向
      • 市場預測
    • 印尼
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 歐洲
    • 德國
      • 市場走向
      • 市場預測
    • 法國
      • 市場走向
      • 市場預測
    • 英國
      • 市場走向
      • 市場預測
    • 義大利
      • 市場走向
      • 市場預測
    • 西班牙
      • 市場走向
      • 市場預測
    • 俄羅斯
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場走向
      • 市場預測
    • 墨西哥
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 中東和非洲
    • 市場走向
    • 按國家/地區分類的市場細分
    • 市場預測

第 10 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 13 章：價格分析

第14章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Abbott Laboratories
    • Bioventus Inc.
    • Boston Scientific Corporation
    • Helius Medical Technologies
    • Integer Holdings Corporation
    • LivaNova PLC
    • Medtronic plc
    • MicroTransponder Inc.
    • Neuronetics
    • NeuroPace Inc.
    • NeuroSigma Inc.
    • Nevro Corp.
Product Code: SR112023A5722

Market Overview:

The global neuromodulation market size reached US$ 6.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 12.5 Billion by 2028, exhibiting a growth rate (CAGR) of 10.4% during 2023-2028.

Neuromodulation is a medical technique used for the modulation and alteration of nerve activities by delivering electrical or pharmaceutical agents directly to the targeted area. It consists of tiny electrodes that generate electrical stimulation with the help of pulse generators to supplement neurological activities in the patients. The electrodes are generally placed in the nerves, brain, or spinal cord, whereas pulse generators are implanted within the skin. Neuromodulation is widely used to treat depression, chronic pain, epilepsy, tremor, migraine, failed back syndrome, Parkinson's disease, and gastroparesis. It includes the vagal nerve, deep brain, transcranial magnetic, and electrical stimulation. It assists in monitoring nerve activity, alleviating symptoms, and normalizing activity levels in the brain.

Neuromodulation Market Trends:

The rising geriatric population and the increasing prevalence of Alzheimer's and Parkinson's diseases across the globe are key factors driving the market growth. Neuromodulation is widely used to treat overactive bladder, low movement, rigidity, tremor, walking problems, neurodegenerative, and neurological disorders. Moreover, technological innovations, such as the introduction of lithium-ion (Li-ion) batteries that provide high energy density, rechargeability, and enhanced cycling temperature, are providing a considerable boost to the market growth. Additionally, the widespread utilization of spinal cord stimulation (SCS) in various medical problems, such as complex regional pain syndrome, neuropathy, nerve damage, failed-back surgery syndrome, and arachnoiditis, is positively impacting the market growth. Apart from this, the increasing usage of deep brain stimulation (DBS) that delivers low bipolar or monopolar electric impulses and is used in the treatment of depression and obsessive-compulsive disorders (OCD) is creating a positive outlook for the market. Other factors, such as extensive research and development (R&D) activities and significant growth in the healthcare industry, are anticipated to drive the market toward growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global neuromodulation market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on technology, biomaterial and application.

Breakup by Technology:

Internal Neuromodulation

Spinal Cord Stimulation (SCS)

Deep Brain Stimulation (DBS)

Vagus Nerve Stimulation (VNS)

Sacral Nerve Stimulation (SNS)

Gastric Electrical Stimulation (GES)

External Neuromodulation

Transcutaneous Electrical Nerve Stimulation (TENS)

Transcranial Magnetic Stimulation (TMS)

Others

Breakup by Biomaterial:

Metallic Biomaterials

Polymeric Biomaterials

Ceramic Biomaterials

Breakup by Application:

Parkinson's Disease

Epilepsy

Depression

Dystonia

Pain Management

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Bioventus Inc., Boston Scientific Corporation, Helius Medical Technologies, Integer Holdings Corporation, LivaNova PLC, Medtronic plc, MicroTransponder Inc., Neuronetics, NeuroPace Inc., NeuroSigma Inc., Nevro Corp.

Key Questions Answered in This Report:

  • How has the global neuromodulation market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global neuromodulation market?
  • What are the key regional markets?
  • What is the breakup of the market based on the technology?
  • What is the breakup of the market based on the biomaterial?
  • What is the breakup of the market based on the application?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global neuromodulation market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Neuromodulation Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Technology

  • 6.1 Internal Neuromodulation
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Spinal Cord Stimulation (SCS)
      • 6.1.2.2 Deep Brain Stimulation (DBS)
      • 6.1.2.3 Vagus Nerve Stimulation (VNS)
      • 6.1.2.4 Sacral Nerve Stimulation (SNS)
      • 6.1.2.5 Gastric Electrical Stimulation (GES)
    • 6.1.3 Market Forecast
  • 6.2 External Neuromodulation
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Transcutaneous Electrical Nerve Stimulation (TENS)
      • 6.2.2.2 Transcranial Magnetic Stimulation (TMS)
      • 6.2.2.3 Others
    • 6.2.3 Market Forecast

7 Market Breakup by Biomaterial

  • 7.1 Metallic Biomaterials
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Polymeric Biomaterials
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Ceramic Biomaterials
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Parkinson's Disease
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Epilepsy
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Depression
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Dystonia
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Pain Management
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 Others
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Bioventus Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Boston Scientific Corporation
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Helius Medical Technologies
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
    • 14.3.5 Integer Holdings Corporation
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
    • 14.3.6 LivaNova PLC
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
    • 14.3.7 Medtronic plc
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 MicroTransponder Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Neuronetics
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
    • 14.3.10 NeuroPace Inc.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
    • 14.3.11 NeuroSigma Inc.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
    • 14.3.12 Nevro Corp.
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials

List of Figures

  • Figure 1: Global: Neuromodulation Market: Major Drivers and Challenges
  • Figure 2: Global: Neuromodulation Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Neuromodulation Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Neuromodulation Market: Breakup by Technology (in %), 2022
  • Figure 5: Global: Neuromodulation Market: Breakup by Biomaterial (in %), 2022
  • Figure 6: Global: Neuromodulation Market: Breakup by Application (in %), 2022
  • Figure 7: Global: Neuromodulation Market: Breakup by Region (in %), 2022
  • Figure 8: Global: Neuromodulation (Internal Neuromodulation) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Neuromodulation (Internal Neuromodulation) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Neuromodulation (External Neuromodulation) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Neuromodulation (External Neuromodulation) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Neuromodulation (Metallic Biomaterials) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Neuromodulation (Metallic Biomaterials) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Neuromodulation (Polymeric Biomaterials) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Neuromodulation (Polymeric Biomaterials) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Neuromodulation (Ceramic Biomaterials) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Neuromodulation (Ceramic Biomaterials) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Neuromodulation (Parkinson's Disease) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Neuromodulation (Parkinson's Disease) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Neuromodulation (Epilepsy) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Neuromodulation (Epilepsy) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Neuromodulation (Depression) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Neuromodulation (Depression) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Neuromodulation (Dystonia) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Neuromodulation (Dystonia) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: Global: Neuromodulation (Pain Management) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: Global: Neuromodulation (Pain Management) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: Global: Neuromodulation (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: Global: Neuromodulation (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: North America: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: North America: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: United States: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: United States: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: Canada: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: Canada: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: Asia-Pacific: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: Asia-Pacific: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: China: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: China: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: Japan: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: Japan: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: India: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: India: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: South Korea: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: South Korea: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: Australia: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: Australia: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: Indonesia: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: Indonesia: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: Others: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: Others: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: Europe: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: Europe: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: Germany: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: Germany: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: France: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: France: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: United Kingdom: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: United Kingdom: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Italy: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Italy: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Spain: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Spain: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Russia: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Russia: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Others: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Others: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Latin America: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Latin America: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Brazil: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Brazil: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: Mexico: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: Mexico: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 74: Others: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 75: Others: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 76: Middle East and Africa: Neuromodulation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 77: Middle East and Africa: Neuromodulation Market: Breakup by Country (in %), 2022
  • Figure 78: Middle East and Africa: Neuromodulation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 79: Global: Neuromodulation Industry: SWOT Analysis
  • Figure 80: Global: Neuromodulation Industry: Value Chain Analysis
  • Figure 81: Global: Neuromodulation Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Neuromodulation Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Neuromodulation Market Forecast: Breakup by Technology (in Million US$), 2023-2028
  • Table 3: Global: Neuromodulation Market Forecast: Breakup by Biomaterial (in Million US$), 2023-2028
  • Table 4: Global: Neuromodulation Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 5: Global: Neuromodulation Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: Neuromodulation Market: Competitive Structure
  • Table 7: Global: Neuromodulation Market: Key Players